Daniel Prins is Global Study Associate Director of Acerta Pharma B.V. (A member of the AstraZeneca Group) based in Kloosterstraat 9 OSS, 5349 AB, NL. Previously worked at ICON plc as a Senior Project Manager. Acerta Pharma B.V. (A member of the AstraZeneca Group) is a Manufacturing, Pharmaceuticals company in Kloosterstraat 9 OSS, 5349 AB, NL with 143 employees.
Daniel Prins has 15 years of professional experience, with an average of 3 years per position throughout their career. Their recent employment history shows 1 changes in the past 3 years, with high job stability. they do not have Fortune 500 company experience.
Daniel Prins holds a degree from Rijksuniversiteit Groningen / University of Groningen, with 15 years since graduation. Their career include experience at a global enterprise.
Acerta Pharma B.V. (A member of the AstraZeneca Group) is founded in 2013, operates from its headquarter in Kloosterstraat 9 OSS, 5349 AB, NL. The company operates in the Manufacturing, Pharmaceuticals sector.
Acerta Pharma B.V. (A member of the AstraZeneca Group) specializes in Drug discovery, Drug development, Cutting edge science, Covalent technology, Haematological oncology research, State-of-the-art research laboratories, and offers services including Novel innovative drugs, Targeted therapies, and New treatment options.
Daniel Prins completed at Rijksuniversiteit Groningen / University of Groningen (2009 - 2011) , at Rijksuniversiteit Groningen / University of Groningen (2005 - 2009) , etc
These email and Phone numbers are the most updated and verified contact information for Daniel Prins found in 2025.